Jinhuan Wang

The combination therapy of Peginterferonα and entecavir for HBeAg-positive chronic hepatitis B with high HCC risk.

Jun Lu, F. Xiong, Xuli Bao, 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Evolution of iron burden in acquired aplastic anemia: a cohort study of more than 3-year follow-up

Jing Zhang, Jin-bo Huang, M. Ge, 2014, International Journal of Hematology.

The effect of thymopentin add-on in hepatitis B e antigen positive chronic hepatitis B after virus suppression by peginterferon plus entecavir therapy.

F. Xiong, Jun Lu, Xuli Bao, 2019, Cellular and molecular biology.

HBsAg Profiles in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2010 .

Serum microRNAs predict response of patients with chronic hepatitis B to antiviral therapy.

F. Xiong, Mei Liu, Jun Lu, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Extended duration therapy regimens based on Pegylated interferon for chronic hepatitis B patients focusing on hepatitis B surface antigen loss: A systematic review and meta-analysis.

Jun Lu, F. Xiong, Jinhuan Wang, 2020, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses.

Ding‐Shinn Chen, Sheng-Nan Lu, J. Kao, 2010, The Journal of infectious diseases.